PET scan for small cell lung cancer diagnosis
Part of Cancer, Lungs & breathing clinical trials.
This study uses a special PET scan (68Ga-PFD3) to take pictures of small cell lung cancer tumors. The goal is to see if this scan can help doctors better diagnose and evaluate the cancer, which may guide treatment decisions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be an adult (18 or older).
- You must have a confirmed diagnosis of small cell lung cancer (SCLC).
- You must have at least one tumor that is 1 cm or larger, seen on a standard scan like CT.
- Blood tests (complete blood count and chemistry) must be done within 4 weeks before starting the study.
- You cannot be pregnant or breastfeeding.
- You must not have any condition that prevents a PET scan (like severe claustrophobia or being over the weight limit).
- You must not have received prior treatment that targets DLL3.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses a special PET/CT scan to look for a protein called DLL3 in small cell lung cancer. The scan may help doctors better see and understand the cancer. You may be able to join if you have suspected or confirmed small cell lung cancer and certain blood markers are high.
This trial tests a special PET/CT imaging scan that may help doctors find where small cell lung cancer (and some related tumors) are in the body using a DLL3 target. It’s a Phase 1/2 study, mainly to see how well the scan detects tumors and guides care.
This trial tests a new type of PET scan that uses a special tracer to find lung tumors. The goal is to see if this scan can better detect cancer cells, which may help doctors plan the best treatment for you.
This study tests a new type of PET/CT scan that looks for a marker called DLL3 on neuroendocrine cancer cells. It aims to see if this scan finds tumors better than standard scans, which could help guide treatment.
This early-phase study tests a special whole-body scan (PET/CT) that uses injected tracers to help show where lung cancer may be. It may help researchers see tumors more clearly and compare different tracers during the same time window.
This trial is testing a new type of PET scan that uses a radioactive tracer called 68Ga-PentixaFor to see if it can better detect metastatic small cell lung cancer compared to standard scans. You may be eligible if you have newly diagnosed, untreated metastatic small cell lung cancer and are about to start your first treatment.
Hear when a new Small Cell Lung Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.